Inventor
KORMOS BETHANY LYN
US14 patents
Patents
14 patentsUS9695171B2Jul 4, 2017
3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors
PFIZER10 citations83
US9642855B2May 9, 2017
Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors
PFIZER6 citations83
US9156845B2Oct 13, 2015
4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors
PFIZER6 citations83
US8933224B2Jan 13, 2015
Triazine derivatives
PFIZER5 citations83
US11542270B2Jan 3, 2023
BCKDK inhibitors
PFIZER6 citations82
US10039753B2Aug 7, 2018
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors
PFIZER14 citations81
US11059833B2Jul 13, 2021
BCKDK inhibitors
PFIZER7 citations80
US9296761B2Mar 29, 2016
Triazine derivatives
PFIZER2 citations62
US11390623B2Jul 19, 2022
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands
PFIZER0 citations60
US11161844B2Nov 2, 2021
Cyclic substituted imidazo[4,5-c]quinoline derivatives
PFIZER1 citations60
US11312713B2Apr 26, 2022
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors
PFIZER0 citations59
US9145427B2Sep 29, 2015
Triazine derivatives
PFIZER3 citations59
US12466803B2Nov 11, 2025
BCKDK inhibitors and/or degraders
PFIZER0 citations56
US10590128B2Mar 17, 2020
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands
PFIZER0 citations49